Cris Pharma (India) Limited, a active public limited company, was established on 01 September 1992 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the agriculture, forestry, fishing sector, it holds CIN: U24139RJ1992PLC034757. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.24 Cr.
It upholds a compliant status. Employing 161 professional, Its leadership includes Poonam Chand Taparia (Whole-Time Director), Kailash Chand Melana (Director), Suwa Lal Jat (Director). Past directors included Vinod Kalani, Raspreet Singh, Rajnikant Chunilal Mehta. It holds ₹3.52 Cr open charges and ₹8.13 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sp-2, 22 Godam Industrial Estate, Jaipur, Rajasthan, 302006.
U24139RJ1992PLC034757
034757
01 September 1992
₹1.25 Cr
₹1.24 Cr
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Cris Pharma (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Poonam Chand Taparia | Whole-Time Director | 25 Aug 1997 | Current |
| Kailash Chand Melana | Director | 20 Mar 2005 | Current |
| Suwa Lal Jat | Director | 25 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Oct 2013 | Past |
| Pramod Abcsdd | Whole-Time Director | 15 Sep 2011 | Past |
| Pramod Abcsdd | Director | 17 Apr 2023 | Past |
| Pramod Abcsdd | Director | 01 Apr 2007 | Past |
| Pramod Abcsdd | Director | 15 Nov 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cris Pharma (India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.15% increase. The company also saw a slight decrease in profitability, with a 5.04% decrease in profit. The company's net worth Soared by an impressive increase of 16.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cris Pharma (India) had a promoter holding of 81.69% and a public holding of 18.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,188,000.00
₹81,317,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2021 | Sidbi | ₹5.00 M | Open |
| 16 Nov 2017 | Others | ₹3.02 Cr | Open |
| 30 Jul 2014 | Hdfc Bank Limited | ₹2.40 Cr | Satisfied |
| 13 Feb 2013 | State Bank Of India | ₹9.00 M | Satisfied |
| 30 Mar 2011 | Small Industrial Development Bank Of India | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Cris Pharma (India) has a workforce of 161 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cris Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cris Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 3.02 Cr registered on 16 Nov 2017 with Charge ID 100171676 was modified on 29 May 2025. was documented.
The activity Cris Pharma (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Cris Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was completed.
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100428021 was registered on 25 Feb 2021. was recorded as a recent event.
A charge registered on 30 Jul 2014 via Charge ID 10513388 with Hdfc Bank Limited was fully satisfied on 26 Feb 2018. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 3.02 Cr with Charge ID 100171676 was registered on 16 Nov 2017. was documented.
The CIN of Cris Pharma (India) Limited is U24139RJ1992PLC034757.
Cris Pharma (India) Limited is headquartered at Sp-2, 22 Godam Industrial Estate, Jaipur, Rajasthan, 302006.
Cris Pharma (India) Limited was incorporated on 01 September 1992.
The current directors of Cris Pharma (India) Limited are
The primary industry of Cris Pharma (India) Limited is Agriculture, Forestry, Fishing.
Cris Pharma (India) Limited is unlisted.
The authorized capital of Cris Pharma (India) Limited is ₹1.25 Cr, and the paid-up capital is ₹1.24 Cr.
The compliance status of Cris Pharma (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX